VERV Chart
See on advanced chart >
About
Verve Therapeutics, Inc. was incorporated on March 9, 2018 as a Delaware corporation. They are a genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course...
Read More
- HighlightA clinical-stage biotech company that pioneers a new approach to the care of cardiovascular disease with single-course gene editing medicines
- ExchangeNASDAQ
- Listing Date06/17/2021
- Established Date03/09/2018
- Full-time Employees204
- Address201 Brookline Avenue Suite 601 Boston Massachusetts 02215
- Tel1-617-6030070
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology
